Gaber Bergant

Mr. Gaber Bergant

Clinical institute for genomic medicine, University medical center Ljubljana, Ljubljana, Slovenia
orcid

Research Focus & Metrics

Academic Career Length

9Years (2018-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 March 2018 in Genetics in Medicine
Verified
Journal Article
Closed access
GBGaber Bergant
Gaber Bergant
AMAles Maver
Ales Maver
LLLuca Lovrecic
Luca Lovrecic
GČGoran Čuturilo
Goran Čuturilo
AHAlenka Hodzic
Alenka Hodzic
BPBorut Peterlin
Borut Peterlin

10 January 2020 in Movement Disorders
Verified
Journal Article
Closed access
PDF file
TWThomas Wirth
Thomas Wirth
LMLouise-Laure Mariani
Louise-Laure Mariani
GBGaber Bergant
Gaber Bergant
MBMichel Baulac
Michel Baulac
MHMarie‐Odile Habert
Marie‐Odile Habert
EREmmanuel Roze
Emmanuel Roze

13 October 2020 in Human Genetics
Verified
Journal Article
Closed access
PDF file
AAAshfaque Ahmed
Ashfaque Ahmed
MWMeng Wang
Meng Wang
GBGaber Bergant
Gaber Bergant
RMReza Maroofian
Reza Maroofian
RZRongjuan Zhao
Rongjuan Zhao
ZHZhengmao Hu
Zhengmao Hu

1 November 2024 in Science
Verified
Journal Article
Closed access
FKFlorian Kraft
Florian Kraft
PRPiere Rodriguez-Aliaga
Piere Rodriguez-Aliaga
WYWeimin Yuan
Weimin Yuan
LFLena Franken
Lena Franken
KZKamil Zajt
Kamil Zajt
IKIngo Kurth
Ingo Kurth
Malformations of the brain are common and vary in severity, from negligible to potentially fatal. Their causes have not been fully elucidated. Here, we report pathogenic variants in the core protein-folding machinery TRiC/CCT in individuals with brain malformations, intellectual disability, and seizures. The chaperonin TRiC is an obligate hetero-oligomer, and we identify variants in seven of its eight subunits, all of which impair function or assembly through different mechanisms. Transcriptome and proteome analyses of patient-derived fibroblasts demonstrate the various consequences of TRiC impairment. The results reveal an unexpected and potentially widespread role for protein folding in the development of the central nervous system and define a disease spectrum of “TRiCopathies.”

5 March 2021 in Life
Verified
Journal Article
Open access
PDF file
GBGaber Bergant
Gaber Bergant
AMAleš Maver
Aleš Maver
BPBorut Peterlin
Borut Peterlin
Several patients with rare genetic disorders remain undiagnosed following comprehensive diagnostic testing using whole-exome sequencing (WES). In these patients, pathogenic genetic variants may reside in intronic or regulatory regions or they may emerge through mutational mechanisms not detected by WES. For this reason, we implemented whole-genome sequencing (WGS) in routine clinical diagnostics of patients with undiagnosed genetic disorders and report on the outcome in 30 patients. Criteria for consideration included (1) negative WES, (2) a high likelihood of a genetic cause for the disorders, (3) positive family history, (4) detection of large blocks of homozygosity or (5) detection of a single pathogenic variant in a gene associated with recessive conditions. We successfully discovered a causative genetic variant in 6 cases, a retrotranspositional event in the APC gene, non-coding variants in the intronic region of the OTC gene and the promotor region of the UFM1 gene, repeat expansion in the RFC1 gene and a single exon duplication in the CNGB3 gene. We also discovered one coding variant, an indel, which was missed by variant caller during WES data analysis. Our study demonstrates the impact of WGS in the group of patients with undiagnosed genetic diseases after WES in the clinical setting and the diversity of mutational mechanisms discovered, which would remain undetected using other methods.

30 December 2022 in Cells
Verified
Journal Article
Open access
PDF file
GBGaber Bergant
Gaber Bergant
DADzhamilyat Abdulkhalikova
Dzhamilyat Abdulkhalikova
AŠAna Šuštaršič
Ana Šuštaršič
BPBorut Peterlin
Borut Peterlin
EVEda Vrtacnik-Bokal
Eda Vrtacnik-Bokal
TPTanja Burnik Papler
Tanja Burnik Papler
Obesity is an increasing worldwide problem, and it is common in women with polycystic ovaries syndrome (PCOS). It is well known that women with PCOS have lower chances of spontaneous conception as well as lower success with IVF procedures. The mechanisms by which obesity causes lower fertility are not yet fully understood. The aim of the present study was to determine the effect of a lifestyle intervention weight loss program on the expression of the endometrial genes during the window of implantation (WOI). For this purpose, 15 infertile women with obesity and PCOS were included in the study. Endometrial samples were taken during the WOI before and at the end of the program, and RNASeq analysis was performed. There were no significantly differentially expressed genes before and after the weight loss program. We then compared the results of our study with previously published studies on markers of endometrial receptivity. The biomarker genes that were found to be down-regulated during the WOI in previous studies were more down-regulated after the weight loss program in the present study. Furthermore, 25% of the women who achieved the desired 5% or more weight reduction conceived spontaneously. Our study shows that weight loss might positively impact endometrial receptivity. which may lead towards the improved fertility of obese women with PCOS.